ClinicalTrials.Veeva

Menu

Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

B

Beijing Chest Hospital

Status

Not yet enrolling

Conditions

Amino Acid Deficiency
Malnutrition
Lung Cancer

Treatments

Dietary Supplement: amino acid tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT05770063
YNLX-2022-011

Details and patient eligibility

About

To investigate whether compound amino acid supplementation can further promote protein synthesis and improve nutritional status for lung cancer patients.

Enrollment

86 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NRS2002 >=3 scores
  • lung cancer patients
  • low albumin or hemoglobin
  • informed consent

Exclusion criteria

  • Acute and critical patients;
  • Severe liver and kidney dysfunction;
  • Patients with gastrointestinal bleeding or intestinal obstruction;
  • Pregnant women, lactating women, people with mental illness, and people without independent behavior ability.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

86 participants in 2 patient groups, including a placebo group

intervention group
Experimental group
Description:
compound amino acid supplement
Treatment:
Dietary Supplement: amino acid tablet
control group
Placebo Comparator group
Description:
placebo
Treatment:
Dietary Supplement: amino acid tablet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems